Xenon Pharmaceuticals Inc (XENE)
40.54
-1.95
(-4.59%)
USD |
NASDAQ |
May 10, 16:00
40.56
+0.02
(+0.05%)
After-Hours: 20:00
Xenon Pharmaceuticals Price to Book Value: 3.297 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 10, 2024 | 3.297 |
| May 09, 2024 | 3.456 |
| May 08, 2024 | 3.491 |
| May 07, 2024 | 3.532 |
| May 06, 2024 | 3.512 |
| May 03, 2024 | 3.558 |
| May 02, 2024 | 3.497 |
| May 01, 2024 | 3.456 |
| April 30, 2024 | 3.306 |
| April 29, 2024 | 3.475 |
| April 26, 2024 | 3.294 |
| April 25, 2024 | 3.261 |
| April 24, 2024 | 3.212 |
| April 23, 2024 | 3.342 |
| April 22, 2024 | 3.254 |
| April 19, 2024 | 3.243 |
| April 18, 2024 | 3.278 |
| April 17, 2024 | 3.386 |
| April 16, 2024 | 3.374 |
| April 15, 2024 | 3.360 |
| April 12, 2024 | 3.359 |
| April 11, 2024 | 3.495 |
| April 10, 2024 | 3.451 |
| April 09, 2024 | 3.499 |
| April 08, 2024 | 3.466 |
| Date | Value |
|---|---|
| April 05, 2024 | 3.436 |
| April 04, 2024 | 3.431 |
| April 03, 2024 | 3.357 |
| April 02, 2024 | 3.371 |
| April 01, 2024 | 3.426 |
| March 28, 2024 | 3.500 |
| March 27, 2024 | 3.496 |
| March 26, 2024 | 3.468 |
| March 25, 2024 | 3.471 |
| March 22, 2024 | 3.577 |
| March 21, 2024 | 3.532 |
| March 20, 2024 | 3.560 |
| March 19, 2024 | 3.605 |
| March 18, 2024 | 3.487 |
| March 15, 2024 | 3.574 |
| March 14, 2024 | 3.55 |
| March 13, 2024 | 3.665 |
| March 12, 2024 | 3.597 |
| March 11, 2024 | 3.607 |
| March 08, 2024 | 3.759 |
| March 07, 2024 | 3.752 |
| March 06, 2024 | 3.736 |
| March 05, 2024 | 3.739 |
| March 04, 2024 | 3.735 |
| March 01, 2024 | 3.808 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.905
Minimum
Oct 28 2020
7.544
Maximum
Nov 05 2021
3.436
Average
3.164
Median
Dec 28 2022
Price to Book Value Benchmarks
| Acasti Pharma Inc | 0.4011 |
| Aurinia Pharmaceuticals Inc | 1.900 |
| Edesa Biotech Inc | 2.502 |
| Lexaria Bioscience Corp | 7.015 |
| ESSA Pharma Inc | 1.962 |
Price to Book Value Related Metrics
| PS Ratio | 205.88 |
| PEG Ratio | -1.059 |
| Price | 40.54 |
| Earnings Yield | -6.71% |
| Market Cap | 3.059B |
| PEGY Ratio | -1.059 |